Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Results of hepatobiliary imaging using Tc-99m EHIDA

Journal Article · · Clin. Nucl. Med.; (United States)

Tc-99m labelled 2,6-diethylphenylcarbamoylmethyliminodiacetic acid (EHIDA) is a non-toxic radiopharmaceutical that was found to undergo rapid biliary excretion in a normal human, with accumulation of radioactivity in the gall bladder and intestine. Images in normal subjects and nonjaundiced patients showed rapid concentration of tracer by the liver and the passage of the same into the intestine within 15 to 40 minutes, with or without visualization of the gall bladder. In the jaundiced patient, the tracer blood clearance was delayed and urinary excretion was increased. Tc-99m EHIDA has been extensively investigated in 1634 patients to evaluate its performance in the diagnosis of hepatobiliary disorders.

Research Organization:
Nuclear Medicine Centre, Rajshahi (Bangladesh)
OSTI ID:
5877861
Journal Information:
Clin. Nucl. Med.; (United States), Journal Name: Clin. Nucl. Med.; (United States) Vol. 14:5; ISSN CNMED
Country of Publication:
United States
Language:
English